...
首页> 外文期刊>The biochemical journal >The rat liver vasoactive intestinal peptide binding site. Molecular characterization by covalent cross-linking and evidence for differences from the intestinal receptor
【24h】

The rat liver vasoactive intestinal peptide binding site. Molecular characterization by covalent cross-linking and evidence for differences from the intestinal receptor

机译:大鼠肝脏血管活性肠肽结合位点。通过共价交联的分子表征和与肠受体差异的证据

获取原文

摘要

pTo identify the molecular components of the vasoactive intestinal peptide (VIP) binding sites in the liver, 125I-labelled VIP was covalently linked to liver membranes by using the cleavable cross-linker dithiobis(succinimidylpropionate). Purified rat liver plasma membranes were incubated with 125I-VIP, washed and treated with 1 mM-cross-linker. Polyacrylamide-gel electrophoresis of membrane proteins followed by autoradiography revealed a major 125I-VIP-protein complex of Mr 51 000. A minor Mr 89 000 complex was also observed. An identical pattern of protein labelling was obtained using crude membranes from rat liver. Labelling of the Mr 51 000 and 89 000 species was specific in that it could be abolished by native VIP, but was unaffected by 1 microM-glucagon and cholecystokinin octapeptide. Densitometric scanning of autoradiographs indicated that the labelling of the two species was abolished by similar low VIP concentrations (0.1-100 nM). It was also reduced by two VIP agonists, peptide histidine isoleucine amide and secretin, with a potency that is 1/7 and 1/200 that of native VIP, respectively. The guanine nucleotide GTP in the concentration range between 10(-7) and 10(-3) M reduces the labelling of the major Mr 51 000 protein and that of the minor Mr 89 000 protein, but with a slightly higher potency. Assuming one molecule of 125I-VIP was bound per molecule of protein, a major Mr 48 000 protein and a minor Mr 86 000 protein were identified as components of the high-affinity VIP binding sites in liver. This contrasts markedly with the pattern of labelling of rat intestinal epithelial membranes, where a Mr 73 000 protein was identified as a high-affinity VIP receptor and a Mr 33 000 protein as a low-affinity VIP binding site [Laburthe, Bréant & Rouyer-Fessard (1984) Eur. J. Biochem. 139, 181-187], suggesting structural differences between VIP binding sites in rat liver and intestinal epithelium./p
机译:为了鉴定肝脏中血管活性肠肽(VIP)结合位点的分子组成,使用可裂解的交联剂二硫代双(琥珀酰亚胺基丙酸酯)将125I标记的VIP与肝膜共价连接。将纯化的大鼠肝质膜与125I-VIP孵育,洗涤并用1 mM交联剂处理。膜蛋白的聚丙烯酰胺凝胶电泳,然后放射自显影显示,主要的125I-VIP-蛋白复合物为5​​1 000先生。还观察到少量的89 000先生复合物。使用大鼠肝脏的粗膜可以得到相同的蛋白质标记模式。先生先生的51000和89000种的标签具有特殊性,因为它可以被天然VIP废除,但不受1 microM-胰高血糖素和八肽胆囊收缩素的影响。放射自显影仪的光密度扫描表明,这两个物种的标记被相似的低VIP浓度(0.1-100 nM)废除了。它也被两种VIP激动剂肽组氨酸异亮氨酸酰胺和促胰液素减少,其效力分别是天然VIP的1/7和1/200。浓度在10(-7)和10(-3)M之间的鸟嘌呤核苷酸GTP降低了主要的Mr 51 000蛋白和次要的Mr 89 000蛋白的标记,但效力略高。假设每分子蛋白质结合一个分子125I-VIP,则鉴定出肝脏中高亲和力VIP结合位点的主要成分为Mr 48 000蛋白和次要Mr 86 000蛋白。这与大鼠肠上皮膜的标记模式形成鲜明对比,其中大鼠Mr 73 000蛋白被鉴定为高亲和力的VIP受体,而Mr 33 000蛋白被鉴定为低亲和力的VIP结合位点[Laburthe,Bréant& A. Rouyer-Fessard(1984)欧洲。 J.生物化学。 139,181-187],表明大鼠肝脏和肠上皮中VIP结合位点之间的结构差异。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号